TEM Tempus Return on Sales by Net Profit

TEM (Tempus AI Inc) - company brandmark

Tempus AI, Inc (TEM) is capturing the personalized treatment segment by leveraging AI to analyze DNA and sell unique analytics to pharmaceutical giants. Net profit margin reflects a turning point driven by the implementation of the oncology platform in clinics and the scaling of subscriptions. Growth is fueled by contracts with Big Pharma, which create a stable cash flow. The value of -12.50 represents the current figure for this metric.

Tempus AI, Inc (TEM) - Net Margin from 06/15/2024 to 11/19/2026

Comprehensive metric breakdowns and analytics for Tempus AI Inc (TEM)

- share price and expert price forecast:
Summary company analysis:Tempus AI, Inc - TEM
Flagship merchandise of Tempus AI, Inc.

Investors utilize this indicator as a barometer of operational efficiency and the issuer's ability to generate profit from every dollar of revenue. The ratio of net income to total sales, reflected through the net profit margin, confirms the ability of Tempus AI, Inc (TEM) management to monetize genomic data sets and integrate AI solutions into diagnostics, transforming technological potential into real financial stability.

Competitor analysis

qiagen.com (QGEN) - Net Margin|Ionis (IONS) - Net Sales Margin|Net Margin Repligen|Avidity (RNA) - Company Sales Margin|Net Sales Margin CRSP|Company Sales Margin GeneDx|Net Margin Ultragenyx RARE|Company Sales Margin Beam Therapeutics (BEAM)|SRPT: Return on Sales by Net Profit|Net Margin Twist Bioscience|TXG (10x Genomics) - Return on Sales by Net Profit|Intellia Therapeutics, Inc. (NTLA) - Net Sales Margin|Net Margin Stoke Therapeutics Inc|BLFS: Net Profit Rate|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX